Ocrevus Zunovo™ (ocrelizumab and hyaluronidase-ocsq)
for Multiple Sclerosis
Ocrevus Zunovo (ocrelizumab and hyaluronidase) is used to treat multiple sclerosis (MS) in adults, including relapsing forms (clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease) and primary progressive MS. It works by targeting and binding to CD20 proteins on B cells, reducing their number. This helps minimize nerve damage, reduce relapses, prevent brain lesions, and slow disability progression.
